NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

Swegen,

I believe that while Dr. Liau is making numerous appearances she won't specifically discuss DCVax-L blinded data till at least TLD is revealed, and I would expect she won't go much deeper than what's in TLD until she's called on to present the detail in depth for peer review. That may be initiated with an Abstract submitted to ASCO, as I suspect, or a Journal publication, as many believe. I believe that both may very well be in the works, and that by agreement she'll present at ASCO just before the Journal publication.

While I believe TLD could be out at or before the Annual Meeting, it would also be possible for them to announce that we'll be presenting at ASCO and that TLD, the update to Clinical Trials, and the ASCO Abstract will all become public on June 3rd. I'm not certain, but the company may even be able to announce the date and time of an ASCO presentation by the time of the Annual Meeting.

I've seen other companies announcing ASCO presentations, but they'd be for Abstracts that were not late breakers, and to date they haven't specified date and time. I do not know if ASCO will actually juggle what's presented on June 3rd when they exhibit the late breaking Abstracts, or if any presentations based on them are already firmly in the schedule. I'm also uncertain if the company makes a presentation in the Experts Forum if that will be scheduled as well. I believe that they can appear in the Experts Forum even if they also are making a formal presentation. I believe in the past they had trial patients speak about their experience at the Experts Forum, something I don't believe they'd do in a technical presentation.

Gary